Larimar Therapeutics Correlations

LRMR Stock

USD 3.21 0.11 3.31%

The current 90-days correlation between Larimar Therapeutics and Nuvectis Pharma is 0.14 (i.e., Average diversification). The correlation of Larimar Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Larimar Therapeutics Correlation With Market

Weak diversification

The correlation between Larimar Therapeutics and DJI is 0.31 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Larimar Stock

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Larimar Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

To learn how to invest in Larimar Stock, please use our How to Invest in Larimar Therapeutics guide.

Moving together with Larimar Stock

0.76	MRK	Merck Company	Pair Corr
0.87	PFE	Pfizer Inc	Pair Corr
0.77	KMDA	Kamada	Pair Corr
0.75	NKTR	Nektar Therapeutics	Pair Corr
0.72	CGEN	Compugen	Pair Corr
0.67	FNMFO	Federal National Mortgage	Pair Corr
0.75	KB	KB Financial Group Earnings Call This Week	Pair Corr
0.81	SHG	Shinhan Financial Earnings Call This Week	Pair Corr
0.85	WF	Woori Financial Group Earnings Call This Week	Pair Corr
0.81	BAC-PL	Bank of America	Pair Corr
0.66	WFC-PL	Wells Fargo	Pair Corr
0.67	CSCO	Cisco Systems	Pair Corr
0.65	INTC	Intel Earnings Call This Week	Pair Corr
0.69	IBM	International Business Earnings Call This Week	Pair Corr
0.66	MSFT	Microsoft	Pair Corr
0.8	CVX	Chevron Corp	Pair Corr
0.63	AXP	American Express	Pair Corr

Moving against Larimar Stock

0.31	BCH	Banco De Chile	Pair Corr
0.64	PG	Procter Gamble	Pair Corr
0.36	HPQ	HP Inc	Pair Corr
0.32	KO	Coca Cola Earnings Call This Week	Pair Corr
0.31	TRV	The Travelers Companies	Pair Corr

Related Correlations Analysis

	REPL	NVCT	LYRA	GOSS	INZY	ORIC	OLMA	KROS	TARA
REPL		-0.37	0.38	0.76	0.66	0.76	-0.04	0.35	-0.3	REPL
NVCT	-0.37		-0.32	-0.59	-0.74	-0.75	0.47	0.36	0.62	NVCT
LYRA	0.38	-0.32		0.41	0.56	0.55	-0.54	0.3	-0.3	LYRA
GOSS	0.76	-0.59	0.41		0.78	0.82	-0.21	0.12	-0.68	GOSS
INZY	0.66	-0.74	0.56	0.78		0.94	-0.52	-0.16	-0.62	INZY
ORIC	0.76	-0.75	0.55	0.82	0.94		-0.39	-0.06	-0.66	ORIC
OLMA	-0.04	0.47	-0.54	-0.21	-0.52	-0.39		0.44	0.16	OLMA
KROS	0.35	0.36	0.3	0.12	-0.16	-0.06	0.44		0.09	KROS
TARA	-0.3	0.62	-0.3	-0.68	-0.62	-0.66	0.16	0.09		TARA
	REPL	NVCT	LYRA	GOSS	INZY	ORIC	OLMA	KROS	TARA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ORIC	+ 0.94	INZY
ORIC	+ 0.82	GOSS
INZY	+ 0.78	GOSS
GOSS	+ 0.76	REPL
ORIC	+ 0.76	REPL
INZY	+ 0.66	REPL

High negative correlations

ORIC	- 0.75	NVCT
INZY	- 0.74	NVCT
TARA	- 0.68	GOSS
TARA	- 0.66	ORIC
TARA	- 0.62	INZY
GOSS	- 0.59	NVCT

Risk-Adjusted Indicators

There is a big difference between Larimar Stock performing well and Larimar Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Larimar Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
REPL	3.61	0.75	0.13	0.97	4.89	(4.11)	9.93	(5.40)	34.70
NVCT	3.09	(0.46)	0.00	(0.18)	0.00	0.00	9.61	(5.98)	18.97
LYRA	12.65	3.54	0.36	4.65	7.90	(20.06)	18.00	(15.85)	342.66
GOSS	4.00	1.10	0.24	1.04	3.65	(5.09)	11.63	(6.67)	28.71
INZY	8.04	3.61	0.59	(3.14)	3.27	(11.66)	10.42	(7.26)	179.17
ORIC	3.99	1.19	0.29	1.24	3.52	(5.02)	10.31	(6.94)	37.54
OLMA	3.42	0.09	0.02	0.22	5.61	(3.30)	6.85	(7.53)	24.73
KROS	1.54	0.14	0.00	(1.51)	2.20	(1.59)	3.36	(4.23)	10.31
TARA	3.22	(0.55)	0.00	(0.25)	0.00	0.00	7.05	(5.57)	25.12

Larimar Therapeutics Corporate Management

Gopi MBA	Chief Officer	Profile
DO Sr	Chief Officer	Profile
Francis Conway	VP Controller	Profile
Sr DO	Chief Officer	Profile
John Berman	Vice Administration	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC